Zacks Research Expects Stronger Earnings for Teladoc Health

Key Points

• Zacks Research has upgraded its earnings per share estimate for Teladoc Health, predicting a loss of ($0.23) for Q3 2025, an improvement from the previous estimate of ($0.24), maintaining a Strong-Buy rating for the stock.
• The company's stock price target has been adjusted upward from $8.00 to $9.00 by Evercore ISI, while Weiss Ratings has issued a sell rating.
• Teladoc Health's share price opened at $8.92, with a significant year-to-date volatility reflected in its 12-month low of $6.35 and a high of $15.21.

Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Equities research analysts at Zacks Research raised their Q3 2025 earnings per share estimates for Teladoc Health in a research report issued on Monday, October 13th. Zacks Research analyst Team now anticipates that the health services provider will earn ($0.23) per share for the quarter, up from their prior forecast of ($0.24). Zacks Research currently has a "Strong-Buy" rating on the stock. The consensus estimate for Teladoc Health's current full-year earnings is ($1.16) per share. Zacks Research also issued estimates for Teladoc Health's Q4 2025 earnings at ($0.17) EPS, FY2025 earnings at ($0.79) EPS, Q1 2026 earnings at ($0.28) EPS, Q2 2026 earnings at ($0.23) EPS, Q4 2026 earnings at ($0.12) EPS, FY2026 earnings at ($0.91) EPS, Q1 2027 earnings at ($0.25) EPS, Q2 2027 earnings at ($0.22) EPS and FY2027 earnings at ($0.90) EPS.

Several other research firms also recently weighed in on TDOC. Evercore ISI increased their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an "in-line" rating in a research report on Wednesday, October 8th. Mizuho initiated coverage on Teladoc Health in a report on Friday, July 25th. They set a "neutral" rating and a $10.00 price target for the company. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of Teladoc Health in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, Teladoc Health presently has a consensus rating of "Hold" and an average target price of $9.86.

Teladoc Health Trading Up 8.1%

Shares of TDOC stock opened at $8.92 on Wednesday. Teladoc Health has a 12-month low of $6.35 and a 12-month high of $15.21. The firm's 50 day moving average is $7.84 and its 200 day moving average is $7.60. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $1.58 billion, a P/E ratio of -7.49 and a beta of 1.90.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. The business had revenue of $631.90 million during the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.Teladoc Health's revenue was down 1.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS.

Institutional Trading of Teladoc Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Golden State Wealth Management LLC lifted its position in Teladoc Health by 102.6% in the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after buying an additional 1,690 shares during the last quarter. National Bank of Canada FI raised its stake in shares of Teladoc Health by 79.4% in the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after acquiring an additional 1,581 shares during the period. SVB Wealth LLC bought a new stake in shares of Teladoc Health in the 1st quarter worth about $37,000. BI Asset Management Fondsmaeglerselskab A S bought a new position in Teladoc Health during the 1st quarter valued at about $50,000. Finally, Caitong International Asset Management Co. Ltd raised its position in Teladoc Health by 8,192.0% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 8,292 shares of the health services provider's stock worth $72,000 after purchasing an additional 8,192 shares during the period. Hedge funds and other institutional investors own 76.82% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.